Home      Site Map      Contact      Links      Medical News      


allergy relief allergies


Generic medication at fraction of the cost. Asthma.
Over 500 generics available for immediate delivery. Orders can be tracked online. 10% rebate for reorders. Full refund option.
Generics at fraction of the cost. Asthma.
Over 500 generics in stock. Licensed online pharmacy. No prescription needed. 10% rebate on reorders. Orders can be tracked online.
Discount accolate Prices
Discount prices - Buy Discount Prescription Drugs and Save Up To 80%.
Generic medication Low prices
Generic medication from Licensed online pharmacy FREE doctors consultation SAVE up to 70%
ACCOLATE: Find More Information here
Get best results for accolate. Get 10 most relevant accolate results.
Accolate
LowPriceShopper for all your shopping needs!
Buy Tramadol Online!
Tramadol. Offer review from dozens of shops. Daily list of the hottest offers on tramadol.
Accolate
LowPriceShopper for all your shopping needs!
Looking For Cheap Viagra??
Compare Prices For Viagra In Top 10 Online DrugStores. Daily Updated!
My EverydayHealth
Create a Homepage. Connect with others like you. Customize a meal plan - It's all free!

allergy relief allergies
DESCRIPTION
Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide allergy relief allergies. The molecular weight of zafirlukast is 575.7 and the structural formula is:



The empirical formula is: C 31 H 33 N 3 O 6 S

Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water allergy relief allergies. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone allergy relief allergies.

ACCOLATE is supplied as 10 and 20 mg tablets for oral administration allergy relief allergies.

Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide allergy relief allergies.


CLINICAL PHARMACOLOGY
Mechanism of Action
Zafirlukast is a selective and competitive receptor antagonist of leukotrieneD 4 and E 4 (LTD 4 and LTE 4 ), components of slow-reacting substance of anaphylaxis(SRSA) allergy relief allergies. Cysteinyl leukotriene production and receptor occupation have been correlatedwith the pathophysiology of asthma, including airway edema, smooth muscle constriction,and altered cellular activity associated with the inflammatory process, whichcontribute to the signs and symptoms of asthma allergy relief allergies. Patients with asthma were foundin one study to be 25-100 times more sensitive to the bronchoconstricting activityof inhaled LTD 4 than nonasthmatic subjects allergy relief allergies.

In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans allergy relief allergies. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs allergy relief allergies. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness allergy relief allergies.

In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges allergy relief allergies. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma allergy relief allergies. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma allergy relief allergies. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge allergy relief allergies.

Clinical Pharmacokinetics and Bioavailability:
Absorption
Zafirlukast is rapidly absorbed following oral administration allergy relief allergies. Peak plasma concentrationsare generally achieved 3 hours after oral administration allergy relief allergies. The absolute bioavailabilityof zafirlukast is unknown allergy relief allergies. In two separate studies, one using a high fat andthe other a high protein meal, administration of zafirlukast with food reducedthe mean bioavailability by approximately 40% allergy relief allergies.

Distribution
Zafirlukast is more than 99% bound to plasma proteins, predominantly albumin allergy relief allergies. The degree of binding was independent of concentration in the clinically relevantrange allergy relief allergies. The apparent steady-state volume of distribution (V SS /F) is approximately70 L, suggesting moderate distribution into tissues allergy relief allergies. Studies in rats using radiolabeledzafirlukast indicate minimal distribution across the blood-brain barrier allergy relief allergies.

Metabolism
Zafirlukast is extensively metabolized allergy relief allergies. The most common metabolic products arehydroxylated metabolites which are excreted in the feces allergy relief allergies. The metabolites ofzafirlukast identified in plasma are at least 90 times less potent as LTD 4receptor antagonists than zafirlukast in a standard in vitro test of activity allergy relief allergies. In vitro studies using human liver microsomes showed that the hydroxylated metabolitesof zafirlukast excreted in the feces are formed through the cytochrome P4502C9 (CYP2C9) pathway allergy relief allergies. Additional in vitro studies utilizing human liver microsomesshow that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymesat concentrations close to the clinically achieved total plasma concentrations(see Drug Interactions ) allergy relief allergies.

Excretion
The apparent oral clearance (CL/f) of zafirlukast is approximately 20 L/h allergy relief allergies. Studiesin the rat and dog suggest that biliary excretion is the primary route of excretion allergy relief allergies. Following oral administration of radiolabeled zafirlukast to volunteers, urinaryexcretion accounts for approximately 10% of the dose and the remainder is excretedin feces allergy relief allergies. Zafirlukast is not detected in urine allergy relief allergies.

In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma allergy relief allergies. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma allergy relief allergies. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg allergy relief allergies. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data allergy relief allergies. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% allergy relief allergies.

The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below allergy relief allergies.

Mean (% Coefficient of Variation) pharmacokinetic
parameters of zafirlukast following single 20 mg
oral dose administration to male volunteers (n=36) C max
ng/mL t max h AUC
ng·h/mL t 1/2
h CL/f
L/h
326 (31.0) 2 (0.5-5.0) 1137 (34) 13.3 (75.6) 19.4 (32)
1 Median and range


Special Populations
Gender: The pharmacokinetics of zafirlukast are similar in males and females allergy relief allergies. Weight-adjusted apparent oral clearance does not differ due to gender allergy relief allergies.

Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed allergy relief allergies.

Elderly: The apparent oral clearance of zafirlukast decreases with age allergy relief allergies. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients allergy relief allergies.

Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained:

Parameter Children age
5-6 years
Mean (% Coefficient
of Variation) Children age
7-11 years
Mean (% Coefficient
of Variation)
C max (ng/mL) 756 (39%) 601 (45%)
AUC (ng·h/mL) 2458 (34%) 2027 (38%)
t max (h) 2.1 (61%) 2.5 (55%)
CL/f (L/h) 9.2 (37%) 11.4 (42%)


Weight unadjusted apparent clearance was 11.4 L/h (42%) in the 7-11 year oldchildren and 9.2 L/h (37%) in the 5-6 year old children, which resulted in greatersystemic drug exposures than that obtained in adults for an identical dose allergy relief allergies. To maintain similar exposure levels in children compared to adults, a dose of10 mg twice daily is recommended in children 5-11 years of age (see DOSAGE ANDADMINISTRATION ) allergy relief allergies.

Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults allergy relief allergies.

Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects allergy relief allergies.

Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects allergy relief allergies.

Drug-Drug Interactions
The following drug interaction studies have been conducted with zafirlukast(see PRECAUTIONS , Drug Interactions ) allergy relief allergies.


Coadministration of multiple doses of zafirlukast (160 mg/day) to steady-statewith a single 25 mg dose of warfarin (a substrate of CYP2C9) resulted in a significantincrease in the mean AUC (+63%) and half-life (+36%) of S-warfarin allergy relief allergies. The meanprothrombin time increased by approximately 35% allergy relief allergies. The pharmacokinetics of zafirlukastwere unaffected by coadministration with warfarin allergy relief allergies.
Coadministration of zafirlukast (80 mg/day) at steady-state with a single doseof a liquid theophylline preparation (6 mg/kg) in 13 asthmatic patients, 18to 44 years of age, resulted in decreased mean plasma concentrations of zafirlukastby approximately 30%, but no effect on plasma theophylline concentrations wasobserved allergy relief allergies.
Coadministration of zafirlukast (20 mg/day) or placebo at steady-state witha single dose of sustained release theophylline preparation (16 mg/kg) in 16healthy boys and girls (6 through 11 years of age) resulted in no significantdifferences in the pharmacokinetic parameters of theophylline allergy relief allergies.
Coadministration of zafirlukast dosed at 40 mg twice daily in a single-blind,parallel-group, 3-week study in 39 healthy female subjects taking oral contraceptives,resulted in no significant effect on ethinyl estradiol plasma concentrationsor contraceptive efficacy allergy relief allergies.
Coadministration of zafirlukast (40 mg/day) with aspirin (650 mg four timesdaily) resulted in mean increased plasma concentrations of zafirlukast by approximately45% allergy relief allergies.
Coadministration of a single dose of zafirlukast (40 mg) with erythromycin (500mg three times daily for 5 days) to steady-state in 11 asthmatic patients resultedin decreased mean plasma concentrations of zafirlukast by approximately 40%due to a decrease in zafirlukast bioavailability allergy relief allergies.


shellfish allergies   allergy control products   flea allergy   food allergy   symptoms of a mold allergy   yeast allergy   allergies and skin rashes   seafood allergy   dog skin allergies   sugar allergy   allergic asthma   onion allergy   asthma plan   allergy rash   oxycodone and allergy   allergy cures   atlanta allergy clinic   cardiac asthma   yeast allergy   asthma and pulmonary hypertension   asthma education   allergy injections   asthma & swimming   asthma care in canada   allergy patient   yeast allergy   children's allergies   asthma central heating   allergic bronchial asthma - chocolate   bee sting allergies   national allergy   dogs allergies   asthma drugs   asthma and allergy foundation   natural asthma treatment   latex allergy   asthma medication in lactation   dog food allergies   allergy tests   asthma puffers   behavioral problems children asthma   asthma action plan   asthma certification   free + asthma guide   asthma quality of life questionnaire   allergy relief products   asthma prevention   allergy to black mold   moccasin foot and asthma   viral asthma   baby asthma   asthma and pulmonary hypertension   allergy season   second hand smoke and asthma   food allergy network   asthma and childhood   asthma treatment guidelines   feline allergies   allergies and pregnancy   safety of asthma medication in lactation   asthma inhalers   asthma questionnaire   peanut allergy symptoms   asthma breather   gluten allergy   accolate   food allergies   scholarships asthma  

abilify  abraxane  accolate  accupril  accutane  acetaminophen  aciphex  aclovate  actifed  activase  actiza  actonel  actos  aczone  adacel  adalat  adderall  adipex  advair  advate  agilect  albalon  albuterol  aldomet  alesse  aleve  alimta  allegra  aloxi  alphagan  alprazolam  altace  altocor  alvesco  amaryl  ambien  amiodarone  amitriptyline  amoxicillin  androgel  angeliq  anidulafungin  antabuse  antegren  anusol  apidra  apokyn  arthrotec  asacol  aspirin  atenolol  ativan  augmentin  avandia  avapro  avastin  avelox  axid 

aallergy relief allergies alllergy relief allergies alllergy relief allergies alleergy relief allergies allerrgy relief allergies allerggy relief allergies allergyy relief allergies allergy relief allergies allergy rrelief allergies allergy reelief allergies allergy rellief allergies allergy reliief allergies allergy relieef allergies allergy relieff allergies allergy relief allergies allergy relief aallergies allergy relief alllergies allergy relief alllergies allergy relief alleergies allergy relief allerrgies allergy relief allerggies allergy relief allergiies allergy relief allergiees allergy relief allergiess llergy relief allergies alergy relief allergies alergy relief allergies allrgy relief allergies allegy relief allergies allery relief allergies allerg relief allergies allergyrelief allergies allergy elief allergies allergy rlief allergies allergy reief allergies allergy relef allergies allergy relif allergies allergy relie allergies allergy reliefallergies allergy relief llergies allergy relief alergies allergy relief alergies allergy relief allrgies allergy relief allegies allergy relief alleries allergy relief allerges allergy relief allergis allergy relief allergie a llergy relief allergies al lergy relief allergies all ergy relief allergies alle rgy relief allergies aller gy relief allergies allerg y relief allergies allergy relief allergies allergy relief allergies allergy r elief allergies allergy re lief allergies allergy rel ief allergies allergy reli ef allergies allergy relie f allergies allergy relief allergies allergy relief allergies allergy relief a llergies allergy relief al lergies allergy relief all ergies allergy relief alle rgies allergy relief aller gies allergy relief allerg ies allergy relief allergi es allergy relief allergie s allergy relief allergies lalergy relief allergies allergy relief allergies alelrgy relief allergies allregy relief allergies allegry relief allergies alleryg relief allergies allerg yrelief allergies allergyr elief allergies allergy erlief allergies allergy rleief allergies allergy reilef allergies allergy releif allergies allergy relife allergies allergy relie fallergies allergy reliefa llergies allergy relief lalergies allergy relief allergies allergy relief alelrgies allergy relief allregies allergy relief allegries allergy relief alleriges allergy relief allergeis allergy relief allergise aallergy relief allergies theallergy relief allergies allergy relief allergies

a  b  c  d  e  f  g  h  i  k  l  m  n  o  p  r  s  t  u  v  w  x  z 

Copyright 2005 D-S LTD.
All Rights Reserved.